ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 151 filers reported holding ATARA BIOTHERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,621 | -3.8% | 10,555 | +4.7% | 0.00% | – |
| Q2 2023 | $16,235 | -45.7% | 10,084 | -2.3% | 0.00% | – |
| Q1 2023 | $29,922 | -11.3% | 10,318 | +0.4% | 0.00% | – |
| Q4 2022 | $33,722 | -13.5% | 10,281 | -0.0% | 0.00% | – |
| Q3 2022 | $39,000 | -56.2% | 10,285 | -9.9% | 0.00% | – |
| Q2 2022 | $89,000 | +27.1% | 11,417 | +3.7% | 0.00% | – |
| Q1 2022 | $70,000 | -60.7% | 11,006 | -2.8% | 0.00% | – |
| Q4 2021 | $178,000 | -10.1% | 11,320 | +2.3% | 0.00% | – |
| Q3 2021 | $198,000 | +3.1% | 11,061 | -10.2% | 0.00% | – |
| Q2 2021 | $192,000 | +6.1% | 12,321 | -2.5% | 0.00% | – |
| Q1 2021 | $181,000 | -29.6% | 12,634 | -3.6% | 0.00% | – |
| Q4 2020 | $257,000 | +78.5% | 13,101 | +18.0% | 0.00% | – |
| Q3 2020 | $144,000 | -12.7% | 11,104 | -1.9% | 0.00% | – |
| Q2 2020 | $165,000 | +3.1% | 11,314 | -39.9% | 0.00% | – |
| Q1 2020 | $160,000 | -6.4% | 18,838 | +81.4% | 0.00% | – |
| Q4 2019 | $171,000 | +52.7% | 10,384 | +31.3% | 0.00% | – |
| Q3 2019 | $112,000 | – | 7,911 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Antipodean Advisors LLC | 1,000,000 | $1,610,000 | 11.42% |
| Redmile Group, LLC | 6,048,123 | $9,737,478 | 0.37% |
| Baupost Group | 9,773,616 | $15,736 | 0.28% |
| JOSH ARNOLD INVESTMENT CONSULTANT, LLC | 170,000 | $273,700 | 0.27% |
| MAVERICK CAPITAL LTD | 6,290,713 | $10,128,048 | 0.22% |
| 683 Capital Management, LLC | 1,000,000 | $1,610,000 | 0.12% |
| WASATCH ADVISORS LP | 8,283,981 | $13,337,209 | 0.08% |
| PACIFIC HEIGHTS ASSET MANAGEMENT LLC | 525,000 | $845,250 | 0.08% |
| STALEY CAPITAL ADVISERS INC | 750,000 | $1,207,500 | 0.06% |
| XTX Topco Ltd | 136,841 | $220,314 | 0.04% |